CNV1014802
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for CNV1014802, covering 2017-10-12 to 2019-01-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia [Phase 2]